Aug. 24 at 10:03 PM
$ISPC since 2017- present.
- addressed the challenge of biospecimen scarcity, with 80% of researchers citing inadequate supply as a research limiter.
- focused on biospecimens makes it highly relevant for medical research requiring organic, biologically derived samples.
- iSpecimen provides access to millions of biospecimens from a global network of providers, covering diverse formats (e.g., fresh, frozen, or banked) and disease states.
- iSpecimen has enhanced its platform with features like the Next Day Quote Program (NDQ). iSpecimen streamlines procurement, harmonizes data, and manages shipping, mirroring Amazon's logistics efficiency. It also handles compliance and contracts, reducing administrative burdens.
- expanded its supplier network for cancer and cardiovascular research.
-
$200 million corporate treasury initiative involving Solana cryptocurrency.
Seems steady and unique in my opinion. Couldn’t find another company based in U.S. with this niche.
$TMO was close (U.S.).
